Combination Of Talazoparib And Enzalutamide In The Treatment Of Metastatic Castration-Resistant Prostate Cancer - EP4593828
EP4593828
- Filing Date
- Sep 29, 2023
- Status
- Pending
- Grant Date
- Aug 6, 2025
- External Links
- Slate, Register, Google Patents
Bibliography
The patent EP4593828A1 was granted to Pfizer on Aug 6, 2025 following the initial filing on Sep 29, 2023 under the application number The current legal status of the patent is Pending.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Get instant alerts for new documents